A study analysing EGFR expression as glioblastoma response to ONC201
Latest Information Update: 13 May 2021
At a glance
- Drugs Dordaviprone (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 13 May 2021 New trial record
- 25 Mar 2021 Results published in the Neuro-Oncology